Mapping of GLP-1 RA Manufacturers — World Health Organization

Original title: WHO Mapping of manufacturers of GLP-1 RA (glucagon-like peptide-1 receptor agonists) manufacturers

Published on March 30, 2026 at 02:43 AMModified on March 30, 2026 at 02:43 AM

Key information

Type: Construction
Location: Multiple countries
Estimated Value: Not disclosed
Language of Notice: English

What is this tender about?

Mapping of GLP-1 RA Manufacturers — World Health Organization is a construction procurement opportunity published by OMS in Multiple countries on March 30, 2026. 1 official document is attached below.

WHO Mapping of manufacturers of GLP-1 RA (glucagon-like peptide-1 receptor agonists) manufacturers WHO WHO Mapping of manufacturers of GLP-1 RA (glucagon-like peptide-1 receptor agonists) manufacturers Request for information Reference: WHO-SHQ-RFI-26-5005 Beneficiary countries or territories: Multiple destinations (see the Countries or territories tab) Published on: 13-Feb-2026 Deadline on: 16-Apr-2026 23:59 (GMT 1.00) Description Announcement 17 March 2026: the deadline of this RFI was extended from 19 March, 23:59 hours, Geneva time (GMT+1) to 16 April 2026, 23:59 hours, Geneva time (GMT+1) This Request For Information (RFI) is to map the manufacturers having GLP1-RA in their portfolio and understanding their regulatory strategy for low- and middle-income countries and information on production capacity, if possible.

See detailed RFI document and submission instructions under “Documents” below. Please note: it is NOT necessary to click on “Express Interest” on the top right-hand side of the screen. In order to inform WHO that you are interested in participating in this Request For Information, please follow the provisions of the RFI document below.

Procuring Entity

Name: OMS

Which documents are available?

Sign in to download the tender documents and be notified automatically of any change to this tender.

Bidding Document